Table 1.
Changes in anthropometric and biochemical parameter postintervention (N = 1453).
| Parameters | Baseline | Postintervention | Mean difference (95% CI) | p value |
|---|---|---|---|---|
| Weight (kg) | ||||
| Mean ± SD | 64 ± 7.7 | 62.3 ± 7.9 | −1.48 (−1.66 to −1.31) | < 0.001 |
| Median (IQR) | 64.2 (10) | 63 (10.1) | ||
| HbA1C (%) | ||||
| Mean ± SD | 7.8 ± 1.8 | 6.6 ± 0.9 | −1.23 (−1.31 to −1.14) | < 0.001 |
| Median (IQR) | 7.4 (2.1) | 6.5 (1.1) | ||
| Fasting blood glucose (mg/dL) | ||||
| Mean ± SD | 140.4 ± 48.9 | 127.2 ± 31.02 | −13.15 (−15.63 to −10.67) | < 0.001 |
| Median (IQR) | 129 (47.8) | 122.2 (34.3) | ||
| Fasting insulin (μU/mL) | ||||
| Mean ± SD | 7.6 ± 6.5 | 7.3 ± 5.4 | −0.35 (−0.67 to −0.04) | 0.025 |
| Median (IQR) | 6.3 (5.6) | 6.1 (4.8) | ||
| HOMA2-IR | ||||
| Mean ± SD | 0.95 ± 0.8 | 0.87 ± 0.7 | −0.07 (−0.12 to −0.03) | 0.001 |
| Median (IQR) | 0.8 (0.7) | 0.7 (0.6) | ||
| HOMA2%B | ||||
| Mean ± SD | 42.8 ± 29.7 | 45.9 ± 30.1 | 3.08 (1.46–4.70) | < 0.001 |
| Median (IQR) | 36.3 (32) | 39.8 (29.9) |
Note: All values for baseline and postintervention are reported as both mean ± SD and median (IQR). Pre- and postintervention measurements were compared by Wilcoxon's signed-rank test. Intervention effects reported as mean differences for all parameters.
Abbreviations: CI, confidence interval; HbA1C, glycated hemoglobin; HOMA2%B, homeostatic model assessment of beta cell function; HOMA2-IR, homeostatic model assessment of insulin resistance; IQR, interquartile range; SD, standard deviation.